跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sulpi-1500 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sulpi-1500
Approved
STANDARD
Sulpi-1500
Reyoung Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5c04f1a54b7e7cf1
Company
Reyoung Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
5c04f1a54b7e7cf1
Drug Approval Philippines Name
Sulpi-1500
Product Name
Sulpi-1500
Registration Number
DRP-11962
Brand Name
Sulpi-1500
Generic Name
Ampicillin (as sodium) + Sulbactam (as sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
1 g/500 mg
Manufacturer
Reyoung Pharmaceutical Co., Ltd.
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
24 May 2022
Expiry Date
24 May 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5c04f1a54b7e7cf1
Type
Standard
Back to Philippines FDA Approvals